Angiodynamic Inc
ANGO
Get informed when a big investor buys or sells
+ FollowMarket Cap$476.15M
Close$
$3.63
68.6% downside
Current Fair Value
68.6% downsideOvervalued by 68.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $476.15 Million |
|---|---|
| Enterprise Value | $452.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.88 |
| Beta | 0.33 |
| Outstanding Shares | 42,022,000 |
Return
| Return on Equity | -20.09% |
|---|---|
| Return on Assets | -13.61% |
| Return on Invested Capital | -12.80% |
Valuation & Multiples
| P/E Ratio | -14.58 |
|---|---|
| PEG | 41.77 |
| Price to Sales | 1.65 |
| Price to Book Ratio | 3.86 |
| Enterprise Value to Revenue | 1.39 |
| Enterprise Value to EBIT | -19.41 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 8, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$80.51 M
Average shareholder expectationNext Earnings Call
Expected Date
January 5, 2027
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$84.03 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.13%▼ 92.08% |
|---|---|
| Total Invested | $808,173▼ 99.84% |
| Investors Holding | 5▼ 158.00% |
ESG Score
No data
About Angiodynamic Inc
CEO: James Clemmer AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines in...